ClinicalTrials.gg
Not yet recruitingNCT06917274Updated Apr 8, 2025

The Banana Exercise Type 1 Diabetes Study

An interventional study of Banana and No banana in Type 1 Diabetes, sponsored by University of Aarhus. Not yet recruiting. Open to participants aged 15 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-04-08.

Sponsored by University of Aarhus · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
15 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus — 6 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 1 · University of Aarhus.

Planned enrollment
9th of 21
20 · median 20
Started
2025
with 2 others
No phase
18 of 24
5 open now
Registered
20th of 24
by date

Among the 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus, this one is the 9th largest by planned enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 20th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

6 of the 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 15 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus, or all of them as a file.
02

Study summary

Former and current KADET athletes participate in two controlled training sessions: one with a banana 20 minutes pre-exercise and one without. Tandem Data recorded includes sensor glucose, training details, insulin dosing, and meal intake. Continuous glucose monitoring (CGM) data is assessed. Endpoints include differences in glucose levels, hypoglycemia events (SG \<3.9 mmol/L), and Time in Range during training

Read the detailed description

Participants:

Former and current KADET athletes invited via a Facebook group. Previous participants in study projects who have expressed interest in being contacted for future studies.

Protocol:

Participants provide written consent for data collection and use.

Each participant completes two training sessions under controlled conditions, including:

Same training time Standardized pre-training meal timing and insulin corrections Similar intensity and environmental factors If pre-training hypoglycemia occurs, training is rescheduled or corrected with glucose tablets, which are documented.

Study Conditions:

Session 1: Participant eats a banana 20 minutes before training. Session 2: No pre-training food intake.

Tandem Control IQ users (insulin pump) take a microbolus (0.05 IE) before banana intake.

Recorded Data by participant:

Training start and end times Sensor glucose (SG) at start and end of training Training type and intensity (Borg scale, heart rate monitoring) Last insulin dose (meal and correction) Last meal details (content and timing) Banana documentation (photo, weight with peel, ripeness level)

CGM data are also assessed.

Endpoints:

Differences in GCG glucose level Time to hypoglycemia and number of hypoglycemia events (SG \<3.9 mmol/L) on banana vs. non-banana days.

Percentage of Time in Range during training. Additional data is reported as available.

03

Conditions studied

  • Type 1 Diabetes

Keywords

  • nutrition
  • CGM
  • blood glucose
  • exercise
04

Who can participate

Ages eligible
15 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • type 1 diabetes

Exclusion criteria

Exclusion Criteria:

  • cardiovascular comorbidity
  • neuropathy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    No banana

    No banana consumed prior exercise

    Other: No banana

  • Active comparator
    banana

    Banana consumed 20 minutes prior exercise

    Dietary Supplement: Banana

Interventions

  • Dietary supplementBanana

    A banana is consumed pre-exercise in order to prevent hypoglycemia

  • OtherNo banana

    No banana is consumed pre-exercise

06

What researchers measure

Primary outcomes

  1. CGM glucose

    CGM glucose Time in Range between 3.9 and 10 mmol/l

    Time frame: approximately 60 minute monitoring period during exercise

Secondary outcomes

  1. Time to hypoglycemia

    minutes to hypoglycemia after exercise has begun

    Time frame: approximately 30 to 30 minutes

  2. Borg scale

    Level of excaution evaluated on Borg scale from 6-20

    Time frame: Borg scale is assessed approximately 15 minutes after exercise

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2025; primary completion for Nov 2025, 7 months later.

Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 7 months is below that.

Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2025
First posted
Apr 8, 2025
StartEst.
Apr 1, 2025
Primary completionEst.
Nov 1, 2025
CompletionEst.
Feb 1, 2026
Last update
Apr 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06917274
Responsible party
Sponsor
First posted
Apr 8, 2025
Start date
Apr 1, 2025 (estimated)
Primary completion
Nov 1, 2025 (estimated)
Completion
Feb 1, 2026 (estimated)
Last update
Apr 8, 2025

Study contacts

Rakel Johansen, MD
Contact
rfjohansen@clin.au.dk
+45 40530612
Esben Vestergaard, MD
Contact
esbevest@rm.dk
21932828

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Banana

Start the discussion